Ken Griffin Quanterix Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.92 - $16.36 $184,548 - $276,484	-16,900 Reduced 62.59%	10,100 $130,000
Q2 2024 Aug 14, 2024	BUY	$12.26 - $23.78 $194,934 - $378,102	15,900 Added 143.24%	27,000 $356,000
Q1 2024 May 15, 2024	BUY	$21.9 - $28.28 $153,300 - $197,960	7,000 Added 170.73%	11,100 $261,000
Q4 2023 Feb 14, 2024	SELL	$19.54 - $28.66 $152,412 - $223,548	-7,800 Reduced 65.55%	4,100 $112,000
Q3 2023 Nov 14, 2023	SELL	$21.15 - $27.96 $105,750 - $139,800	-5,000 Reduced 29.59%	11,900 $322,000
Q2 2023 Aug 14, 2023	BUY	$11.16 - $23.65 $84,816 - $179,740	7,600 Added 81.72%	16,900 $381,000
Q1 2023 May 15, 2023	SELL	$10.12 - $14.91 $49,587 - $73,059	-4,900 Reduced 34.51%	9,300 $104,000
Q4 2022 Feb 14, 2023	SELL	$8.75 - $14.02 $92,750 - $148,612	-10,600 Reduced 42.74%	14,200 $196,000
Q3 2022 Nov 14, 2022	BUY	$7.46 - $19.28 $185,008 - $478,144	24,800 New	24,800 $273,000

153

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $435M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.